相关实验视频

Updated: May 9, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

专利聚焦于针对纤维细胞激活蛋白的治疗药物,用于个性化癌症护理

Jason A Witek¹, Allen F Brooks¹, Benjamin L Viglianti¹

¹Department of Radiology, University of Michigan, Ann Arbor, MI, USA.

Pharmaceutical patent analyst

|May 6, 2025

概括

精确瘤学正在与神经神经学一起发展,将成像和治疗结合起来. 这项专利聚焦点分析了向纤维细胞激活蛋白 (FAP) 的放射性药物,为这种有前途的泛癌方法提供了洞察力.

科学领域:

在瘤学瘤学.
放射性药物疗法是一种放射性药物疗法.
分子成像学分子成像学

背景情况:

热诺斯基融合了诊断成像和向治疗,以改善癌症患者的治疗结果,特别是在晚期疾病中.
最近的FDA批准和商业化已经加速了对神经复杂剂的投资和开发.
纤维细胞激活蛋白 (FAP) 是一个有前途的泛癌点,因为它在各种瘤类型中的广泛表达.

研究的目的:

提供与向纤维细胞激活蛋白 (FAP) 的放射性药物相关的专利的首次全面分析.
确定目前的趋势,挑战和未来发展方向,以 FAP 为基础的天文学.

主要方法:

对已颁发的专利进行系统审查和分析,重点关注针对FAP的放射性药物.
评估专利范围,治疗应用和诊断能力.

主要成果:

确定针对FAP的放射性药物专利的关键创新者和趋势.
专利FAP向剂的治疗和诊断潜力的分析.
围绕 FAP theranostics 的知识产权景观的概述.

结论:

针对FAP的放射性药物代表了精密瘤学的重大创新领域.
专利分析揭示了一个充满活力的领域,具有实质性的学术和商业利益.
进一步开发和战略专利对于推进广泛癌症应用的基于FAP的治疗术至关重要.

关键词:

FAPIAPI FAPIAPI 这是一个很好的方法.在PET成像中使用PET成像.热浪学是什么意思热浪学纤维细胞激活蛋白质的激活蛋白质放射化学放射化学是指辐射化学.辐射疗法辐射疗法

更多相关视频

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Introduction to Fibroblasts

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...